{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:41:52Z","timestamp":1788907312930,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00774-022-01397-5","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T16:02:47Z","timestamp":1673452967000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Possible involvement of CXCR3-CXCR6\u2009+\u2009CD4\u2009+\u2009T cells in Langerhans cell histiocytosis"],"prefix":"10.1007","volume":"41","author":[{"given":"Akemi","family":"Tokutsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-7139","authenticated-orcid":false,"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"1397_CR1","first-page":"84","volume":"56","author":"L Liechtenstein","year":"1953","unstructured":"Liechtenstein L (1953) Histiocytosis X: integration of eosinophilic granuloma, \u201cLetterer-Siwe disease\u201d, and \u201dSchuller-Christian dis- ease\u201d as related manifestations of a single nosologic entity. AMA Arch Pathol 56:84\u2013102","journal-title":"AMA Arch Pathol"},{"key":"1397_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-8-72","volume":"8","author":"M Girschikofsky","year":"2013","unstructured":"Girschikofsky M, Arico M, Castillo D, Chu A, Doberauer C et al (2013) Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis 8:72. https:\/\/doi.org\/10.1186\/1750-1172-8-72","journal-title":"Orphanet J Rare Dis"},{"key":"1397_CR3","doi-asserted-by":"publisher","first-page":"18678","DOI":"10.18632\/oncotarget.7892","volume":"7","author":"C Lian","year":"2016","unstructured":"Lian C, Lu Y, Shen S (2016) Langerhans cell histiocytosis in adults: a case report and review of the literature. Oncotarget 7:18678\u201318683. https:\/\/doi.org\/10.18632\/oncotarget.7892","journal-title":"Oncotarget"},{"key":"1397_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(sici)1096-911x(199701)28:1<9::aid-mpo3>3.0.co;2-p","volume":"28","author":"I Baumgartner","year":"1997","unstructured":"Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F (1997) Langerhans\u2019-cell histiocytosis in adults. Med Pediatr Oncol 28:9\u201314. https:\/\/doi.org\/10.1002\/(sici)1096-911x(199701)28:1%3c9::aid-mpo3%3e3.0.co;2-p","journal-title":"Med Pediatr Oncol"},{"key":"1397_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/107327481402100409","volume":"21","author":"N Grana","year":"2014","unstructured":"Grana N (2014) Langerhans cell histiocytosis. Cancer Control 21:328\u2013334. https:\/\/doi.org\/10.1177\/107327481402100409","journal-title":"Cancer Control"},{"key":"1397_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.26412","volume":"97","author":"XX Cao","year":"2022","unstructured":"Cao XX, Duan MH, Zhao AL, Cai H, Chen J et al (2022) Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. Am J Hematol 97:203\u2013208. https:\/\/doi.org\/10.1002\/ajh.26412. (Epub 2021 Nov 23)","journal-title":"Am J Hematol"},{"key":"1397_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0889-8588(05)70509-8","volume":"12","author":"JS Malpas","year":"1998","unstructured":"Malpas JS (1998) Langerhans cell histiocytosis in adults. Hematol Oncol Clin North Am 12:259\u2013268. https:\/\/doi.org\/10.1016\/s0889-8588(05)70509-8","journal-title":"Hematol Oncol Clin North Am"},{"key":"1397_CR8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/art.40180","volume":"69","author":"S Kubo","year":"2017","unstructured":"Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K et al (2017) Peripheral Immunophenotyping identifies three subgroups based on T Cell heterogeneity in lupus patients. Arthritis Rheumatol 69:2029\u20132037. https:\/\/doi.org\/10.1002\/art.40180","journal-title":"Arthritis Rheumatol"},{"key":"1397_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker HT, McCoy JP, Nussenblatt R (2012) Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol 12:191\u2013200. https:\/\/doi.org\/10.1038\/nri3158","journal-title":"Nat Rev Immunol"},{"key":"1397_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12185-016-1993-3","volume":"104","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H et al (2016) Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Int J Hematol 104:99\u2013109. https:\/\/doi.org\/10.1007\/s12185-016-1993-3","journal-title":"Int J Hematol"},{"key":"1397_CR11","first-page":"4195","volume":"94","author":"RM Egeler","year":"1999","unstructured":"Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94:4195\u20134201","journal-title":"Blood"},{"key":"1397_CR12","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1111\/cas.13817","volume":"109","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Tojo A (2018) Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment. Cancer Sci 109:3707\u20133713. https:\/\/doi.org\/10.1111\/cas.13817","journal-title":"Cancer Sci"},{"key":"1397_CR13","doi-asserted-by":"publisher","first-page":"154877","DOI":"10.1016\/j.cyto.2019.154877","volume":"126","author":"MB Ismail","year":"2020","unstructured":"Ismail MB, \u00c5kefeldt SO, Lourda M, Gavhed D, Aric\u00f2 M et al (2020) High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis. Cytokine 126:154877. https:\/\/doi.org\/10.1016\/j.cyto.2019.154877","journal-title":"Cytokine"},{"key":"1397_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","volume":"180","author":"SP Singh","year":"2008","unstructured":"Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180:214\u2013221. https:\/\/doi.org\/10.4049\/jimmunol.180.1.214","journal-title":"J Immunol"},{"key":"1397_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.71.1.1","volume":"71","author":"S Aggarwal","year":"2002","unstructured":"Aggarwal S, Gurney AL (2002) IL-17: Prototype member of an emerging cytokine family. J Leukoc Biol 71:1\u20138","journal-title":"J Leukoc Biol"},{"key":"1397_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467\u2013476. https:\/\/doi.org\/10.1016\/j.immuni.2004.08.018","journal-title":"Immunity"},{"key":"1397_CR17","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.1003370","volume":"186","author":"B P\u00f6llinger","year":"2011","unstructured":"P\u00f6llinger B, Junt T, Metzler B, Walker UA, Tyndall A et al (2011) Th17 cells, not IL-17+ \u03b3\u03b4 T cells, drive arthritic bone destruction in mice and humans. J Immunol 186:2602\u20132612. https:\/\/doi.org\/10.4049\/jimmunol.1003370","journal-title":"J Immunol"},{"key":"1397_CR18","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1359\/jbmr.2002.17.11.1926","volume":"17","author":"J Kamizono","year":"2002","unstructured":"Kamizono J, Okada Y, Shirahata A, Tanaka Y (2002) Bisphosphonate induces remission of refractory osteolysis in Langerhans cell histiocytosis. J Bone Miner Res 17:1926\u20131928. https:\/\/doi.org\/10.1359\/jbmr.2002.17.11.1926","journal-title":"J Bone Miner Res"},{"key":"1397_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cyto.2014.07.002","volume":"70","author":"Y Oh","year":"2014","unstructured":"Oh Y, Morimoto A, Shioda Y, Imamura T, Kudo K, Imashuku S, Japan LCH Study Group (2014) High serum osteopontin levels in pediatric patients with high risk Langerhans cell histiocytosis. Cytokine 70:194\u2013197. https:\/\/doi.org\/10.1016\/j.cyto.2014.07.002","journal-title":"Cytokine"},{"key":"1397_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/ijlh.13304","volume":"42","author":"N Li","year":"2020","unstructured":"Li N, Cui L, Ma H, Gong Z, Lian H et al (2020) Osteopontin is highly secreted in the cerebrospinal fluid of patient with posterior pituitary involvement in Langerhans cell histiocytosis. Int J Lab Hematol 42:788\u2013795. https:\/\/doi.org\/10.1111\/ijlh.13304","journal-title":"Int J Lab Hematol"},{"key":"1397_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nm1694","volume":"14","author":"F Coury","year":"2008","unstructured":"Coury F, Annels N, Rivollier A, Olsson S, Santoro A et al (2008) Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14:81\u201387. https:\/\/doi.org\/10.1038\/nm1694","journal-title":"Nat Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-022-01397-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T02:15:48Z","timestamp":1679883348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-022-01397-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1007\/s00774-022-01397-5","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"6 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"A signed consent form was obtained from the patient regarding the publication of the clinical information in an international medical journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}